Cross Modal Correlation of EEG and MRI Functional Connectivity: An Investigative Study

April 20, 2026 updated by: Shay Efrati, Assaf-Harofeh Medical Center
Cross modal correlation of EEG and MRI functional connectivity: An Investigative Study. Correlating EEG Analysis with Brain Network Connectivity in Functional MRI. The primary aim of this study is to correlate correlation of MRI and EEG.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Cross modal correlation of EEG and MRI functional connectivity: An Investigative Study. Correlating EEG Analysis with Brain Network Connectivity in fMRI. The primary aim of this study is to correlate correlation of MRI and EEG. The expected study duration is approximately 24 months (first patient in to last patient out). Estimated Enrolment: 1500 Subjects.

The aim of this study is to correlate between fMRI and EEG. Overall, the integration of AI into the study of correlations between EEG and fMRI for brain network analysis holds great promise for advancing our understanding of brain function.

Upon consent, eligible participants will be invited for EEG evaluation. EEG will be obtained using a dry electrodes headset. Correlation between fMRI and EEG connectivity for each EEG frequency band across different configurations (brain atlas, EEG connectivity measure).

EEG data will undergo pre-processing of filtering, electrical line noise removal, artifact removal and down sampling. EEG analysis for each state, comprising within and between participant data, will include frequency analysis (peak frequency and relative power), oscillations (proportions of the activity of the alpha, beta, theta, and delta bands) and power spectra distribution. Functional connectivity analysis will be performed including functional coupling.

For evoked response potentials analysis, data will be segmented to trials/epochs. Bad trials will be excluded from analysis. Included trials data will be averaged. Event-related synchronization (ERS) / desynchronization (ERD) will be evaluated.

Study Type

Interventional

Enrollment (Estimated)

1500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Zrifin, Israel, 70300
        • Recruiting
        • The Sagol Center for Hyperbaric Medicine and Research Shamir Medical Center (Assaf Harofeh)
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male or females aged 18 years or older.
  • Performed a brain MRI at the Sagol Center MRI Unit, at the Shamir Medical Center
  • Able to cooperate in an EEG evaluation
  • Can read and sign the informed consent.

Exclusion Criteria:

  • Any scalp/bone abnormality incompatible with the EEG electrodes
  • Any known allergy to metals.
  • Inability to cooperate with simple instructions.
  • Inability to read and sign the informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Electroencephalography (EEG)
EEG excels in capturing rapid changes in neural activity, making it ideal for investigating the dynamic nature of brain networks. It can detect millisecond-level fluctuations in electrical brain signals, allowing precise timing of neural events and interactions between brain regions.
EEG uses small sensors paced on the scalp to record the brain's electrical activity.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation of fMRI and EEG functional connectivity.
Time Frame: The expected study duration is approximately 24 months (first patient in to last patient out)
Examines how brain connectivity patterns measured by fMRI (blood-flow activity) relate to connectivity patterns measured by EEG (electrical activity).
The expected study duration is approximately 24 months (first patient in to last patient out)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between EEG to anatomical MRI findings
Time Frame: The expected study duration is approximately 24 months (first patient in to last patient out)
Investigates how electrical brain activity (EEG) corresponds to structural brain features or abnormalities seen on anatomical MRI.
The expected study duration is approximately 24 months (first patient in to last patient out)
Correlation between EEG to clinical diagnosis, cognitive and physical parameters.
Time Frame: The expected study duration is approximately 24 months (first patient in to last patient out)
Explores how EEG findings relate to a patient's medical diagnosis, cognitive functioning (e.g., memory, attention), and physical/neurological condition.
The expected study duration is approximately 24 months (first patient in to last patient out)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Shai Efrati, MD, Study Principal Investigator

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 2, 2024

Primary Completion (Estimated)

January 31, 2030

Study Completion (Estimated)

January 31, 2030

Study Registration Dates

First Submitted

February 25, 2026

First Submitted That Met QC Criteria

April 16, 2026

First Posted (Actual)

April 20, 2026

Study Record Updates

Last Update Posted (Actual)

April 22, 2026

Last Update Submitted That Met QC Criteria

April 20, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on MRI, Functional MRI

Clinical Trials on EEG

Subscribe